INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 66 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is 21.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $140,000 | +0.7% | 34,599 | +4.6% | 0.00% | – |
| Q4 2016 | $139,000 | -47.3% | 33,090 | -14.7% | 0.00% | -100.0% |
| Q3 2016 | $264,000 | +18.4% | 38,798 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $223,000 | +26.7% | 38,498 | +52.7% | 0.00% | 0.0% |
| Q1 2016 | $176,000 | -3.3% | 25,214 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | -8.1% | 25,214 | +10.0% | 0.00% | 0.0% |
| Q3 2015 | $198,000 | -44.1% | 22,924 | +4.6% | 0.00% | 0.0% |
| Q2 2015 | $354,000 | – | 21,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|